Improving accuracy in stent selection, from Endeavour 2017.
Elise Sutherland and her team (Marc Stringer, Fay Gibson, Elizabeth Griffiths and Anya Rossello) presented their Stelect biomedical engineering technology at Endeavour 2017. Stelect went on to receive $60,000 in funding as winners of the Medtech’s Got Talent competition.
Improving heart surgery outcomes
Stelect aims to improve stent selection for heart surgeries by helping surgeons select the right stent length and diameter. It uses sensory technology to create a visual representation and 3D model of the artery to get the required dimensions.
70% of the time a stent of incorrect size is inserted into the patient, and once it’s inserted, there’s nothing they can really do about it, except putting additional stents in. Winning this event also shows how much as company we have grown. From starting in the BioDesign Innovation subject, to graduating and now to being in a startup, raising capital and on a pathway to potentially improve and add value to the healthcare industry. It’s something we are very proud of and we cannot wait to see what the future holds. Elise Sutherland, co-founder of Stelect and Master of Engineering (Biomedical with Business)
BioDesign Innovation is a unique and interdisciplinary biomedical engineering subject. It enables Master of Engineering students to work in a team with Master of Business Administration students to create a prototype and develop a supporting business plan.